维普中文期刊产品整合服务
75篇 您的检索式:作者名="ERDEN G"
    题名 作者 年代 出处 被引量
1Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion显示文摘AIM: To compare three initial monthly intravitreal ranibizumab(IVR) injections followed by pro re nata(PRN) dosing with one initial monthly IVR injections followed by PRN dosing for macular edema(ME) secondary to branch retinal vein occlusion(BRVO).METHODS: Forty-two eyes of 42 patients who had IVR injections for BRVO were retrospectively studied. Eighteen eyes received 1 initial IVR injection(1+PRN group) and 24 eyes received 3 monthly IVR injections(3+PRN). At 1, 3, 6 and 12mo; spectral-domain optical coherence tomography(SD-OCT) was performed. Central macular thickness(CMT), the integrity of the external limiting membrane(ELM), the presence of subretinal fluid, cyst size, the presence of inner segment/outer segment(IS/OS) defect were determined.RESULTS: At baseline the mean CMT was 521.3±153.2 μm in the 3+PRN group while it was 438.1±162.4 μm in 1+PRN group. At the final visit, mean CMT was 278.3±87.8 μm in the 3+PRN group and 285.2±74.2 μm in the 1+PRN group(P=0.079). The changes in CMT over the entire study period were also comparable in both groups(243±160 μm in the 3+PRN group, and 152.9±175.3 μm in the 1+PRN group; P=0.090). At baseline, best-corrected visual acuity(BCVA) was 0.92±0.60 logarithm of the minimal angle of resolution(logMAR) in the 3+PRN group, while it was 0.72±0.46 logMAR in the 1+PRN group. Final BCVA was 0.42±0.55 logMAR in the 3+PRN group and 0.38±0.50 logMAR in the 1+PRN group(P=0.979). Additionally, the BCVA changes from baseline to final visit were not significantly different(-0.50±0.45 logMAR in the 3+PRN group, and-0.33±0.39 logMAR in the 1+PRN group; P=0.255).CONCLUSION: No significant differences in the anatomical or functional results are found between 3+PRN and 1+PRN regimens in the patients receiving ranibizumab for ME secondary to BRVO. Intact IS/OS and baseline BCVA are good predictor of the visual gain, while baseline CMT is a good predictor of the anatomical gain.Alper Halil Bayat Akin Cakir Seyma Gülcenur Ozturan Selim Bolükbasi Burak Erden Mustafa Nuri Elcioglu 2018International Journal of Ophthalmology(English edition)2018,11,9:6
2Effects of Fenton pre- treatment on waste activated sludge properties 显示文摘ERDEN G FILIBELI A 2011Clean-Soil Air Water2011,39,7:1
3The quality of group tacit knowledge 显示文摘ERDEN Z KROGH G V NONAKA I 2008Journal of Strategic Information Systems2008,17,:1
4Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypot- hyroidism显示文摘Turhan S Sezer S Erden G 2008Ann Soudi Med2008,28,2:1
5Antioxidant enzyme activities and malondialdehyde levels related to aging显示文摘Mine Erden ?nal Güng?r Kanbak Emine Sunal 2001Clinica Chimica Acta2001,,1:1
6Plasma homocysteine con- centrations and serum lipid profile as atherosclerotic risk factors in subclinical hypot-hyroidism显示文摘Turhan S Sezer S Erden G ef al 2008Ann Med2008,28,2:1
7Chemical pretreatment of landfill leachate discharged into municipal biological treatment systems 显示文摘Pala A Erden G 2004Environmental Engineering Science2004,21,5:1
8Knowledge Sharing in an On- line Community of Volunteers: the Role of Community Mu- nificence显示文摘Erden Z Von Krogh G Kim S 2013European Management Review2013,9,4:1
9The effect of magnesium sulfate treatment on serum cardiac troponin I levels in pre-eclamptic women 显示文摘Atalay C Erden G Turhan T 2005Acta Obstet Gynecol Scand2005,84,7:1
10Improving anaerobic biodegradability of biological sludges by Fenton pre-treatment:effects on single stage and two-stage anaerobic digestion显示文摘ERDEN G FILIBELI A 0,,1:1
11Esophagitis Impairs Esophageal Smooth Muscle Reactivity in the Rat Model: An In Vitro Study显示文摘Melih Tugay Firuzan Yildiz Tijen Utkan Bahar Müezzinoglu Faruk Erden Nejat Gacar Güner Ulak 2003Digestive Diseases and Sciences2003,,11:1
12Disintegration of biological sludge : Effect of ozone oxidation and ultrasonic treatment on aerobic digestibility 显示文摘Erden G Demir O Filibeli A 2010Bioresource Technology2010,101,21:1
13Plasma homoeysteine concen- trations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism显示文摘Turhan S Sezer S Erden G 2008Ann Saudi Med2008,28,2:1
14Plasma homocysteine concen- trations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism显示文摘Turban S Sezer S Erden G etal 2008Ann Med2008,28,2:1
15Development of supercapacitor active composites by electrochemical deposition of polypyrrole on carbon nanofibres 显示文摘Dumanh A G Erden A Ytiriim Y 2012Polymer Bulletin2012,68,5:1
16Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study显示文摘Hasan Mutlu ?eyda Gündüz Halit Karaca Abdullah Büyük?elik Yasemin Benderli Cihan Abdülsamet Erden Zeki Akca Hasan ?enol Co?kun 2014Medical Oncology2014,,8:1
17Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism显示文摘Turban S Sezer S Erden G 2008Ann Saudi Med2008,28,2:1
18Reduction of pain oninjection of propofol using meperidine and remifentanil 显示文摘BasaTanoglu G Erden V Delatioglu H 2005Eur JAnaesthesiol2005,22,11:1
19Plasma homocysteine concen- trations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism 显示文摘Turhan S Sezer S Erden G 2008Ann Saudi Med2008,28,2:1
20Reduction of pain on injection of propofol using mepiridine and remifentanil显示文摘Basaranoglu G Erden V Delatioglu H 2005Eur J Anaesthesiol2005,22,11:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费